Hepatoprotective therapy in Kawasaki disease: biochemical improvement and the unresolved question of clinical benefit

Kentaro Ueno

Open source

DOI
10.21037/tp-2026-0892
Published
2026-10
Container
Translational Pediatrics
Publisher
AME Publishing Company
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21037/tp-2026-0892,
  title = {Hepatoprotective therapy in Kawasaki disease: biochemical improvement and the unresolved question of clinical benefit},
  author = {Kentaro Ueno},
  year = {2026},
  journal = {Translational Pediatrics},
  doi = {10.21037/tp-2026-0892},
  url = {https://doi.org/10.21037/tp-2026-0892}
}

RIS

TY  - JOUR
TI  - Hepatoprotective therapy in Kawasaki disease: biochemical improvement and the unresolved question of clinical benefit
AU  - Kentaro Ueno
PY  - 2026
JO  - Translational Pediatrics
DO  - 10.21037/tp-2026-0892
UR  - https://doi.org/10.21037/tp-2026-0892
ER  - 

APA

Ueno, K. (2026). Hepatoprotective therapy in Kawasaki disease: biochemical improvement and the unresolved question of clinical benefit. Translational Pediatrics. https://doi.org/10.21037/tp-2026-0892

Source records